Inactive Instrument

Biondvax Pharmaceuticals Ltd Stock

Stocks

End-of-day quote TEL AVIV STOCK EXCHANGE Other stock markets
- ^ILa	-

19-07-16	Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	PU
19-07-08	Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	PU
19-06-26	Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	PU
19-06-18	Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	PU
19-06-10	Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	PU

Manager	Title	Age	Since
Amir Reichman CEO	Chief Executive Officer	51	2021-03-01
Uri Ben-Or DFI	Director of Finance/CFO	54	2006-12-31
Dalit Fischer CTO	Chief Tech/Sci/R&D Officer	-	2021-12-31

Director	Title	Age	Since
Mark Germain CHM	Chairman	77	2019-09-29
Samuel Moed BRD	Director/Board Member	64	2020-03-23
Adi Raviv BRD	Director/Board Member	71	2020-03-23

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	+1.70%	+6.89%	+2.76%	+7.65%	49.15B
REVOLUTION MEDICINES, INC.	+0.92%	+6.21%	+408.85%	+607.44%	40.23B
IQVIA HOLDINGS INC.	+1.89%	+11.06%	+25.75%	-7.89%	34.55B
BEONE MEDICINES AG	+5.46%	+8.10%	+21.83%	+66.94%	33.09B
CELLTRION, INC.	+3.96%	+6.07%	+14.14%	+37.68%	25.19B
ASCENDIS PHARMA A/S	+2.51%	+4.94%	-	-	17.05B
MEDPACE HOLDINGS, INC.	+2.58%	+7.24%	+71.03%	+132.17%	15.92B
EUROFINS SCIENTIFIC SE	+0.32%	+1.58%	+14.34%	+19.26%	13.83B
ICON PUBLIC LIMITED COMPANY	-1.14%	+7.52%	+14.75%	-30.83%	13.26B
Average	+1.64%	+5.99%	+71.68%	+104.05%	26.92B
Weighted average by Cap.	+1.74%	+6.31%	+89.14%	+131.73%

Employees

Sector